Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224255217> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4224255217 endingPage "S456" @default.
- W4224255217 startingPage "S455" @default.
- W4224255217 abstract "Purpose Routine surveillance endomyocardial biopsy (EMB) following heart transplantation (HT) is considered an important tool for early detection of allograft rejection. However, the recommended frequency of EMB is not defined by societal guidelines and scheduling practices are widely variable between transplant centers. We sought to identify whether there were differences in hemodynamic, echocardiographic or outcome parameters between patients categorized by rejection grade on surveillance EMB. Methods We examined LVEF by echocardiography and right heart catheterization (RHC) hemodynamic parameters obtained at the time of routine surveillance EMB in 222 patients who underwent HT between January 2015 - January 2021 at a single center. Results On the first four post-transplant paired EMBs and RHCs, similar hemodynamic measurements and LVEFs were observed regardless of corresponding cellular rejection grade (P > 0.5) (Table 1). Patients were then grouped by if they ever had a biopsy with significant rejection (SR) defined as ≥ grade 2R (n=119, 54%) or no significant rejection (NSR) defined as grade 0 or 1R (n=103, 46%). Kaplan-Meier survival analysis showed no significant difference in post-transplant survival (HR 0.56, p=0.14) in SR vs NSR (Figure 1). A total of 26 deaths were observed (16 NSR and 10 SR). For those that died in the SR group, only one may have been related to allograft rejection with the cause of death being outside hospital sudden death. In a SR sub-group of 39 patients with ≥3 episodes of grade 2R mortality was low (n=3, 8%). Conclusion We observed minimal hemodynamic, echocardiographic or prognostic implications of cellular rejection detected by routine surveillance EMB. These findings lend support to the practice of limiting high frequency routine surveillance EMB in post-HT patients, even in the early period when non-invasive diagnostics are not applicable. Routine surveillance endomyocardial biopsy (EMB) following heart transplantation (HT) is considered an important tool for early detection of allograft rejection. However, the recommended frequency of EMB is not defined by societal guidelines and scheduling practices are widely variable between transplant centers. We sought to identify whether there were differences in hemodynamic, echocardiographic or outcome parameters between patients categorized by rejection grade on surveillance EMB. We examined LVEF by echocardiography and right heart catheterization (RHC) hemodynamic parameters obtained at the time of routine surveillance EMB in 222 patients who underwent HT between January 2015 - January 2021 at a single center. On the first four post-transplant paired EMBs and RHCs, similar hemodynamic measurements and LVEFs were observed regardless of corresponding cellular rejection grade (P > 0.5) (Table 1). Patients were then grouped by if they ever had a biopsy with significant rejection (SR) defined as ≥ grade 2R (n=119, 54%) or no significant rejection (NSR) defined as grade 0 or 1R (n=103, 46%). Kaplan-Meier survival analysis showed no significant difference in post-transplant survival (HR 0.56, p=0.14) in SR vs NSR (Figure 1). A total of 26 deaths were observed (16 NSR and 10 SR). For those that died in the SR group, only one may have been related to allograft rejection with the cause of death being outside hospital sudden death. In a SR sub-group of 39 patients with ≥3 episodes of grade 2R mortality was low (n=3, 8%). We observed minimal hemodynamic, echocardiographic or prognostic implications of cellular rejection detected by routine surveillance EMB. These findings lend support to the practice of limiting high frequency routine surveillance EMB in post-HT patients, even in the early period when non-invasive diagnostics are not applicable." @default.
- W4224255217 created "2022-04-26" @default.
- W4224255217 creator A5004878944 @default.
- W4224255217 creator A5037600750 @default.
- W4224255217 creator A5042061829 @default.
- W4224255217 creator A5073425675 @default.
- W4224255217 date "2022-04-01" @default.
- W4224255217 modified "2023-10-18" @default.
- W4224255217 title "Acute 2R Cellular Rejection on Routine Surveillance Endomyocardial Biopsy is Not Associated with Significant Hemodynamic Changes on Right Heart Catheterization" @default.
- W4224255217 doi "https://doi.org/10.1016/j.healun.2022.01.1150" @default.
- W4224255217 hasPublicationYear "2022" @default.
- W4224255217 type Work @default.
- W4224255217 citedByCount "0" @default.
- W4224255217 crossrefType "journal-article" @default.
- W4224255217 hasAuthorship W4224255217A5004878944 @default.
- W4224255217 hasAuthorship W4224255217A5037600750 @default.
- W4224255217 hasAuthorship W4224255217A5042061829 @default.
- W4224255217 hasAuthorship W4224255217A5073425675 @default.
- W4224255217 hasConcept C126322002 @default.
- W4224255217 hasConcept C164705383 @default.
- W4224255217 hasConcept C178853913 @default.
- W4224255217 hasConcept C2775934546 @default.
- W4224255217 hasConcept C2777385415 @default.
- W4224255217 hasConcept C2778849806 @default.
- W4224255217 hasConcept C2780073493 @default.
- W4224255217 hasConcept C2911091166 @default.
- W4224255217 hasConcept C2993634958 @default.
- W4224255217 hasConcept C3019189323 @default.
- W4224255217 hasConcept C71924100 @default.
- W4224255217 hasConceptScore W4224255217C126322002 @default.
- W4224255217 hasConceptScore W4224255217C164705383 @default.
- W4224255217 hasConceptScore W4224255217C178853913 @default.
- W4224255217 hasConceptScore W4224255217C2775934546 @default.
- W4224255217 hasConceptScore W4224255217C2777385415 @default.
- W4224255217 hasConceptScore W4224255217C2778849806 @default.
- W4224255217 hasConceptScore W4224255217C2780073493 @default.
- W4224255217 hasConceptScore W4224255217C2911091166 @default.
- W4224255217 hasConceptScore W4224255217C2993634958 @default.
- W4224255217 hasConceptScore W4224255217C3019189323 @default.
- W4224255217 hasConceptScore W4224255217C71924100 @default.
- W4224255217 hasIssue "4" @default.
- W4224255217 hasLocation W42242552171 @default.
- W4224255217 hasOpenAccess W4224255217 @default.
- W4224255217 hasPrimaryLocation W42242552171 @default.
- W4224255217 hasRelatedWork W198116098 @default.
- W4224255217 hasRelatedWork W2018740107 @default.
- W4224255217 hasRelatedWork W2074852113 @default.
- W4224255217 hasRelatedWork W2094589685 @default.
- W4224255217 hasRelatedWork W23877633 @default.
- W4224255217 hasRelatedWork W29262166 @default.
- W4224255217 hasRelatedWork W2999534359 @default.
- W4224255217 hasRelatedWork W2999964781 @default.
- W4224255217 hasRelatedWork W3119668654 @default.
- W4224255217 hasRelatedWork W4224255217 @default.
- W4224255217 hasVolume "41" @default.
- W4224255217 isParatext "false" @default.
- W4224255217 isRetracted "false" @default.
- W4224255217 workType "article" @default.